Request for Covid-19 Impact Assessment of this Report
The United States Decitabine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Decitabine market, reaching US$ million by the year 2028. As for the Europe Decitabine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Decitabine players cover Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., and Otsuka Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Decitabine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Primary MDS
Secondary MDS
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Decitabine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Decitabine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Decitabine by Country/Region, 2017, 2022 & 2028
2.2 Decitabine Segment by Type
2.2.1 10 Mg Dosage Forms
2.2.2 15 Mg Dosage Forms
2.2.3 25 Mg Dosage Forms
2.3 Decitabine Sales by Type
2.3.1 Global Decitabine Sales Market Share by Type (2017-2022)
2.3.2 Global Decitabine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Decitabine Sale Price by Type (2017-2022)
2.4 Decitabine Segment by Application
2.4.1 Primary MDS
2.4.2 Secondary MDS
2.5 Decitabine Sales by Application
2.5.1 Global Decitabine Sale Market Share by Application (2017-2022)
2.5.2 Global Decitabine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Decitabine Sale Price by Application (2017-2022)
3 Global Decitabine by Company
3.1 Global Decitabine Breakdown Data by Company
3.1.1 Global Decitabine Annual Sales by Company (2020-2022)
3.1.2 Global Decitabine Sales Market Share by Company (2020-2022)
3.2 Global Decitabine Annual Revenue by Company (2020-2022)
3.2.1 Global Decitabine Revenue by Company (2020-2022)
3.2.2 Global Decitabine Revenue Market Share by Company (2020-2022)
3.3 Global Decitabine Sale Price by Company
3.4 Key Manufacturers Decitabine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Decitabine Product Location Distribution
3.4.2 Players Decitabine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Decitabine by Geographic Region
4.1 World Historic Decitabine Market Size by Geographic Region (2017-2022)
4.1.1 Global Decitabine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Decitabine Annual Revenue by Geographic Region
4.2 World Historic Decitabine Market Size by Country/Region (2017-2022)
4.2.1 Global Decitabine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Decitabine Annual Revenue by Country/Region
4.3 Americas Decitabine Sales Growth
4.4 APAC Decitabine Sales Growth
4.5 Europe Decitabine Sales Growth
4.6 Middle East & Africa Decitabine Sales Growth
5 Americas
5.1 Americas Decitabine Sales by Country
5.1.1 Americas Decitabine Sales by Country (2017-2022)
5.1.2 Americas Decitabine Revenue by Country (2017-2022)
5.2 Americas Decitabine Sales by Type
5.3 Americas Decitabine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Decitabine Sales by Region
6.1.1 APAC Decitabine Sales by Region (2017-2022)
6.1.2 APAC Decitabine Revenue by Region (2017-2022)
6.2 APAC Decitabine Sales by Type
6.3 APAC Decitabine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Decitabine by Country
7.1.1 Europe Decitabine Sales by Country (2017-2022)
7.1.2 Europe Decitabine Revenue by Country (2017-2022)
7.2 Europe Decitabine Sales by Type
7.3 Europe Decitabine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Decitabine by Country
8.1.1 Middle East & Africa Decitabine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Decitabine Revenue by Country (2017-2022)
8.2 Middle East & Africa Decitabine Sales by Type
8.3 Middle East & Africa Decitabine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Decitabine
10.3 Manufacturing Process Analysis of Decitabine
10.4 Industry Chain Structure of Decitabine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Decitabine Distributors
11.3 Decitabine Customer
12 World Forecast Review for Decitabine by Geographic Region
12.1 Global Decitabine Market Size Forecast by Region
12.1.1 Global Decitabine Forecast by Region (2023-2028)
12.1.2 Global Decitabine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Decitabine Forecast by Type
12.7 Global Decitabine Forecast by Application
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Decitabine Product Offered
13.1.3 Johnson & Johnson Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Eli Lilly and Company
13.2.1 Eli Lilly and Company Company Information
13.2.2 Eli Lilly and Company Decitabine Product Offered
13.2.3 Eli Lilly and Company Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly and Company Main Business Overview
13.2.5 Eli Lilly and Company Latest Developments
13.3 Pharmachemie B.V.
13.3.1 Pharmachemie B.V. Company Information
13.3.2 Pharmachemie B.V. Decitabine Product Offered
13.3.3 Pharmachemie B.V. Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pharmachemie B.V. Main Business Overview
13.3.5 Pharmachemie B.V. Latest Developments
13.4 Otsuka Pharmaceutical
13.4.1 Otsuka Pharmaceutical Company Information
13.4.2 Otsuka Pharmaceutical Decitabine Product Offered
13.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Otsuka Pharmaceutical Main Business Overview
13.4.5 Otsuka Pharmaceutical Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Decitabine Product Offered
13.5.3 Sandoz Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Dr Reddy's Laboratories
13.6.1 Dr Reddy's Laboratories Company Information
13.6.2 Dr Reddy's Laboratories Decitabine Product Offered
13.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dr Reddy's Laboratories Main Business Overview
13.6.5 Dr Reddy's Laboratories Latest Developments
13.7 Accord Healthcare
13.7.1 Accord Healthcare Company Information
13.7.2 Accord Healthcare Decitabine Product Offered
13.7.3 Accord Healthcare Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Accord Healthcare Main Business Overview
13.7.5 Accord Healthcare Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Decitabine Product Offered
13.8.3 Sun Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Decitabine Product Offered
13.9.3 Cipla Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Lupin
13.10.1 Lupin Company Information
13.10.2 Lupin Decitabine Product Offered
13.10.3 Lupin Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lupin Main Business Overview
13.10.5 Lupin Latest Developments
13.11 Shandong Xinshidai Pharmaceutical
13.11.1 Shandong Xinshidai Pharmaceutical Company Information
13.11.2 Shandong Xinshidai Pharmaceutical Decitabine Product Offered
13.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shandong Xinshidai Pharmaceutical Main Business Overview
13.11.5 Shandong Xinshidai Pharmaceutical Latest Developments
13.12 Hangzhou Zhongmei Huadong Pharmaceutical
13.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Offered
13.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.13 ZHENGDA Tianqing Pharmaceutical Group
13.13.1 ZHENGDA Tianqing Pharmaceutical Group Company Information
13.13.2 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Offered
13.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ZHENGDA Tianqing Pharmaceutical Group Main Business Overview
13.13.5 ZHENGDA Tianqing Pharmaceutical Group Latest Developments
13.14 Jiangsu Aosaikang Pharmaceutical
13.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.14.2 Jiangsu Aosaikang Pharmaceutical Decitabine Product Offered
13.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.14.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.15 Jiangsu Haosen Pharmaceutical Group
13.15.1 Jiangsu Haosen Pharmaceutical Group Company Information
13.15.2 Jiangsu Haosen Pharmaceutical Group Decitabine Product Offered
13.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
13.15.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
13.16 Lianyungang Jierui Pharmaceutical
13.16.1 Lianyungang Jierui Pharmaceutical Company Information
13.16.2 Lianyungang Jierui Pharmaceutical Decitabine Product Offered
13.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Lianyungang Jierui Pharmaceutical Main Business Overview
13.16.5 Lianyungang Jierui Pharmaceutical Latest Developments
13.17 Qilu Pharmaceutical Hainan
13.17.1 Qilu Pharmaceutical Hainan Company Information
13.17.2 Qilu Pharmaceutical Hainan Decitabine Product Offered
13.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Qilu Pharmaceutical Hainan Main Business Overview
13.17.5 Qilu Pharmaceutical Hainan Latest Developments
13.18 Lianyungang Runzhong Pharmaceutical
13.18.1 Lianyungang Runzhong Pharmaceutical Company Information
13.18.2 Lianyungang Runzhong Pharmaceutical Decitabine Product Offered
13.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.18.5 Lianyungang Runzhong Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Decitabine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Decitabine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10 Mg Dosage Forms
Table 4. Major Players of 15 Mg Dosage Forms
Table 5. Major Players of 25 Mg Dosage Forms
Table 6. Global Decitabine Sales by Type (2017-2022) & (K Units)
Table 7. Global Decitabine Sales Market Share by Type (2017-2022)
Table 8. Global Decitabine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Decitabine Revenue Market Share by Type (2017-2022)
Table 10. Global Decitabine Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Decitabine Sales by Application (2017-2022) & (K Units)
Table 12. Global Decitabine Sales Market Share by Application (2017-2022)
Table 13. Global Decitabine Revenue by Application (2017-2022)
Table 14. Global Decitabine Revenue Market Share by Application (2017-2022)
Table 15. Global Decitabine Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Decitabine Sales by Company (2020-2022) & (K Units)
Table 17. Global Decitabine Sales Market Share by Company (2020-2022)
Table 18. Global Decitabine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Decitabine Revenue Market Share by Company (2020-2022)
Table 20. Global Decitabine Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Decitabine Producing Area Distribution and Sales Area
Table 22. Players Decitabine Products Offered
Table 23. Decitabine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Decitabine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Decitabine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Decitabine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Decitabine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Decitabine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Decitabine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Decitabine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Decitabine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Decitabine Sales by Country (2017-2022) & (K Units)
Table 35. Americas Decitabine Sales Market Share by Country (2017-2022)
Table 36. Americas Decitabine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Decitabine Revenue Market Share by Country (2017-2022)
Table 38. Americas Decitabine Sales by Type (2017-2022) & (K Units)
Table 39. Americas Decitabine Sales Market Share by Type (2017-2022)
Table 40. Americas Decitabine Sales by Application (2017-2022) & (K Units)
Table 41. Americas Decitabine Sales Market Share by Application (2017-2022)
Table 42. APAC Decitabine Sales by Region (2017-2022) & (K Units)
Table 43. APAC Decitabine Sales Market Share by Region (2017-2022)
Table 44. APAC Decitabine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Decitabine Revenue Market Share by Region (2017-2022)
Table 46. APAC Decitabine Sales by Type (2017-2022) & (K Units)
Table 47. APAC Decitabine Sales Market Share by Type (2017-2022)
Table 48. APAC Decitabine Sales by Application (2017-2022) & (K Units)
Table 49. APAC Decitabine Sales Market Share by Application (2017-2022)
Table 50. Europe Decitabine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Decitabine Sales Market Share by Country (2017-2022)
Table 52. Europe Decitabine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Decitabine Revenue Market Share by Country (2017-2022)
Table 54. Europe Decitabine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Decitabine Sales Market Share by Type (2017-2022)
Table 56. Europe Decitabine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Decitabine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Decitabine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Decitabine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Decitabine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Decitabine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Decitabine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Decitabine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Decitabine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Decitabine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Decitabine
Table 67. Key Market Challenges & Risks of Decitabine
Table 68. Key Industry Trends of Decitabine
Table 69. Decitabine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Decitabine Distributors List
Table 72. Decitabine Customer List
Table 73. Global Decitabine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Decitabine Sales Market Forecast by Region
Table 75. Global Decitabine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Decitabine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Decitabine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Decitabine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Decitabine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Decitabine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Decitabine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Decitabine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Decitabine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Decitabine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Decitabine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Decitabine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Decitabine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Decitabine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Decitabine Revenue Market Share Forecast by Application (2023-2028)
Table 93. Johnson & Johnson Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Decitabine Product Offered
Table 95. Johnson & Johnson Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Eli Lilly and Company Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly and Company Decitabine Product Offered
Table 100. Eli Lilly and Company Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Eli Lilly and Company Main Business
Table 102. Eli Lilly and Company Latest Developments
Table 103. Pharmachemie B.V. Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pharmachemie B.V. Decitabine Product Offered
Table 105. Pharmachemie B.V. Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Pharmachemie B.V. Main Business
Table 107. Pharmachemie B.V. Latest Developments
Table 108. Otsuka Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 109. Otsuka Pharmaceutical Decitabine Product Offered
Table 110. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Otsuka Pharmaceutical Main Business
Table 112. Otsuka Pharmaceutical Latest Developments
Table 113. Sandoz Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sandoz Decitabine Product Offered
Table 115. Sandoz Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sandoz Main Business
Table 117. Sandoz Latest Developments
Table 118. Dr Reddy's Laboratories Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr Reddy's Laboratories Decitabine Product Offered
Table 120. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Dr Reddy's Laboratories Main Business
Table 122. Dr Reddy's Laboratories Latest Developments
Table 123. Accord Healthcare Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 124. Accord Healthcare Decitabine Product Offered
Table 125. Accord Healthcare Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Accord Healthcare Main Business
Table 127. Accord Healthcare Latest Developments
Table 128. Sun Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 129. Sun Pharmaceutical Decitabine Product Offered
Table 130. Sun Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Sun Pharmaceutical Main Business
Table 132. Sun Pharmaceutical Latest Developments
Table 133. Cipla Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 134. Cipla Decitabine Product Offered
Table 135. Cipla Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Cipla Main Business
Table 137. Cipla Latest Developments
Table 138. Lupin Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 139. Lupin Decitabine Product Offered
Table 140. Lupin Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Lupin Main Business
Table 142. Lupin Latest Developments
Table 143. Shandong Xinshidai Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 144. Shandong Xinshidai Pharmaceutical Decitabine Product Offered
Table 145. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Shandong Xinshidai Pharmaceutical Main Business
Table 147. Shandong Xinshidai Pharmaceutical Latest Developments
Table 148. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 149. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Offered
Table 150. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 152. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 153. ZHENGDA Tianqing Pharmaceutical Group Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 154. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Offered
Table 155. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. ZHENGDA Tianqing Pharmaceutical Group Main Business
Table 157. ZHENGDA Tianqing Pharmaceutical Group Latest Developments
Table 158. Jiangsu Aosaikang Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Aosaikang Pharmaceutical Decitabine Product Offered
Table 160. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Jiangsu Aosaikang Pharmaceutical Main Business
Table 162. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 163. Jiangsu Haosen Pharmaceutical Group Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 164. Jiangsu Haosen Pharmaceutical Group Decitabine Product Offered
Table 165. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Jiangsu Haosen Pharmaceutical Group Main Business
Table 167. Jiangsu Haosen Pharmaceutical Group Latest Developments
Table 168. Lianyungang Jierui Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 169. Lianyungang Jierui Pharmaceutical Decitabine Product Offered
Table 170. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Lianyungang Jierui Pharmaceutical Main Business
Table 172. Lianyungang Jierui Pharmaceutical Latest Developments
Table 173. Qilu Pharmaceutical Hainan Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 174. Qilu Pharmaceutical Hainan Decitabine Product Offered
Table 175. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Qilu Pharmaceutical Hainan Main Business
Table 177. Qilu Pharmaceutical Hainan Latest Developments
Table 178. Lianyungang Runzhong Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors
Table 179. Lianyungang Runzhong Pharmaceutical Decitabine Product Offered
Table 180. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. Lianyungang Runzhong Pharmaceutical Main Business
Table 182. Lianyungang Runzhong Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Decitabine
Figure 2. Decitabine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Decitabine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Decitabine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Decitabine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10 Mg Dosage Forms
Figure 10. Product Picture of 15 Mg Dosage Forms
Figure 11. Product Picture of 25 Mg Dosage Forms
Figure 12. Global Decitabine Sales Market Share by Type in 2021
Figure 13. Global Decitabine Revenue Market Share by Type (2017-2022)
Figure 14. Decitabine Consumed in Primary MDS
Figure 15. Global Decitabine Market: Primary MDS (2017-2022) & (K Units)
Figure 16. Decitabine Consumed in Secondary MDS
Figure 17. Global Decitabine Market: Secondary MDS (2017-2022) & (K Units)
Figure 18. Global Decitabine Sales Market Share by Application (2017-2022)
Figure 19. Global Decitabine Revenue Market Share by Application in 2021
Figure 20. Decitabine Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Decitabine Revenue Market Share by Company in 2021
Figure 22. Global Decitabine Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Decitabine Revenue Market Share by Geographic Region in 2021
Figure 24. Global Decitabine Sales Market Share by Region (2017-2022)
Figure 25. Global Decitabine Revenue Market Share by Country/Region in 2021
Figure 26. Americas Decitabine Sales 2017-2022 (K Units)
Figure 27. Americas Decitabine Revenue 2017-2022 ($ Millions)
Figure 28. APAC Decitabine Sales 2017-2022 (K Units)
Figure 29. APAC Decitabine Revenue 2017-2022 ($ Millions)
Figure 30. Europe Decitabine Sales 2017-2022 (K Units)
Figure 31. Europe Decitabine Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Decitabine Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Decitabine Revenue 2017-2022 ($ Millions)
Figure 34. Americas Decitabine Sales Market Share by Country in 2021
Figure 35. Americas Decitabine Revenue Market Share by Country in 2021
Figure 36. United States Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Decitabine Sales Market Share by Region in 2021
Figure 41. APAC Decitabine Revenue Market Share by Regions in 2021
Figure 42. China Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Decitabine Sales Market Share by Country in 2021
Figure 49. Europe Decitabine Revenue Market Share by Country in 2021
Figure 50. Germany Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Decitabine Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Decitabine Revenue Market Share by Country in 2021
Figure 57. Egypt Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Decitabine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Decitabine in 2021
Figure 63. Manufacturing Process Analysis of Decitabine
Figure 64. Industry Chain Structure of Decitabine
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...